Gravidity and parity have strong inverse relations with endometrial cancer occurrence. To determine whether gravidity masks an association with other reproductive factors, the authors analyzed data from a cohort study of 24,848 postmenopausal Iowa women aged 55-69 years who were cancer free at baseline in 1986 and who had not had a hysterectomy. During 5 years of follow-up, 167 incident endometrial cancer cases were documented. As expected, the mean gravidity of cases was lower than that of noncases (2.6 vs. 3.5, p < 0.0001). Endometrial cancer occurrence was associated positively with early age at menarche, late age at natural menopause, and total length of ovulation span, but history of infertility and ages at first and last pregnancy were unrelated to risk after adjustment for gravidity. Two additional factors remained statistically significant independent of gravidity: a history of ever (vs. never) having had an induced abortion (relative risk = 2.5, 95% confidence interval 1.1-5.7) and timing of spontaneous abortions (miscarriages). Results suggest that a miscarriage late in reproductive life, followed by lack of a subsequent full-term pregnancy, may be a marker for progesterone deficiency. If so, the findings support the "unopposed" estrogen hypothesis for the etiology of endometrial cancer. Am J Epidemiol 1996;143:1195-202. abortion, induced; endometrial neoplasms; infertility; miscarriage; pregnancy; prospective studies; reproductive history
There is considerable evidence that reproductive factors play a role in the etiology of endometrial cancer (1-7). Nulliparity and/or nulligravidity have been consistently associated with increased risk (1, 3, (7) (8) (9) , while associations with other reproductive factors such as infertility, numbers of spontaneous and/or induced abortions, and ages at first and last pregnancy have not been consistent (5) (6) (7) (10) (11) (12) . However, the independent effects of these other reproductive factors are difficult to assess because of the possible confounding influence of parity and/or gravidity. The interrelations are complex, and the exact contribution of each factor remains unclear.
Some studies have found a positive association between infertility and endometrial cancer, but only in younger, premenopausal women (8, 10, 13) . Other studies have found no association (4) or that only infertility associated with progesterone deficiencies or anovulatory cycles is associated with increased risk of endometrial cancer (10, 14, 15) . A recent case-control study noted that infertility was associated with a relative risk of 1.8 for endometrial cancer, but this estimate was not statistically significant (1) . Although the issue of infertility has been investigated frequently, results remain inconsistent.
Similarly, previous research on the role of spontaneous and/or induced abortions has yielded inconsistent findings. Many studies have failed to find any association between abortion and endometrial cancer (1, 4, 9, 13, (16) (17) (18) . Others have reported an inverse association with endometrial cancer, but the influence of parity and/or gravidity on these findings has been unclear (7, 8, 18) .
Recent research has focused on the role of ages at first and last pregnancy in the etiology of endometrial cancer. Although most studies found no association with age at first pregnancy (1, 5, 7, 8, 11, 12, 16, 17) , two studies did report an inverse association (4, 19) . Age at last pregnancy has generally been found to be inversely associated with endometrial cancer (4, 7, 11) . However, in many of these studies, adjustments for parity were not described in sufficient detail to evaluate the findings fully.
The present study examined the independent association of infertility, incidence, and timing of spontaneous and induced abortion and ages at first and last pregnancy with endometrial cancer incidence with proper control for gravidity. Unique observations are presented on the timing of miscarriages and their association with endometrial cancer.
MATERIALS AND METHODS

The Iowa Women's Health Study
In January 1986, a health questionnaire was mailed to a random sample of Iowa women aged 55-69 years who were listed in the 1985 Iowa driver's license file. A total of 41,837 women completed and returned the questionnaire, which represented a response rate of 42.7 percent. Deaths that subsequently occurred in Iowa were found by linkage with state vital records. Information on emigration from Iowa was obtained by two follow-up questionnaires through the National Change of Address Service of the US Postal Service. To identify out-of-state deaths, we used the National Death Index of the National Center for Health Statistics.
Data collection
The baseline questionnaire asked for demographic information such as race, occupation, and education and included detailed questions about health and medical history. Included were items about known endometrial risk factors (exogenous hormone use, parity/ gravidity, and body weight) and other gynecologic and reproductive factors, such as ages at menarche and menopause, numbers of miscarriages and/or induced abortions, and history of infertility (defined as trying without success for 1 year to get pregnant). Also included was a paper tape measure to record circumferences of the waist (1 inch (25.4 mm) above the umbilicus) and hips (maximal protrusion). These measurements were used to compute the waist-to-hip circumference ratio. Body mass index (BMI) was calculated as weight (kg)/height (m) 2 . The measurements obtained by this protocol have been shown to have good accuracy and reliability (20) .
Identification of cases of endometrial cancer
The cohort of women considered at risk for endometrial cancer excluded those who at baseline reported having had a prior hysterectomy (n = 14,721). We also excluded women who were premenopausal (n = 545) and those with a previous cancer at a site other than the skin (n = 1,723). After these exclusions, a total of 24,848 women were available for analysis.
Follow-up information on the occurrence of endometrial cancer (International Classification of Diseases for Oncology code 182) was obtained from the State Health Registry of Iowa, part of the National Cancer Institute's Surveillance, Epidemiology, and End Results Program. Incident cases were identified through a computer match of endometrial cancer cases listed in the registry from 1986 to 1990, and study participants were identified by name, birth date, social security number, and zip code. Analyses detailing the mortality and cancer experience of respondents compared with nonrespondents have been published (21) .
Data analysis
Standard longitudinal analysis methods were used, accruing person-years of follow-up for each subject from the date of questionnaire completion to one of the following dates: endometrial cancer diagnosis, death, loss to follow-up, or December 1, 1990, whichever came first.
Ages at first and last pregnancies were stratified a priori into four age categories: less than 20, 20-24, 25-29, and 30 or more years. Number of miscarriages was stratified into three categories: none, one, and two or more. Miscarriages were classified according to their place in the pregnancy history: first, middle, or last pregnancy. Self-reported history of infertility was stratified into two categories (yes or no), as was reported history of induced abortion (ever or never). Years of ovulation for each woman were calculated by totaling the years of reproductive life between menarche and menopause and then subtracting the total months or years of pregnancy. Additional adjustments for estimated months of breastfeeding (estimated by the authors as 6 months per child) and/or for duration of oral contraceptive use did not significantly change the association between total ovulation-years and risk of endometrial cancer. Because incomplete pregnancies were of major interest, we adjusted for gravidity (total number of pregnancies) in our analyses rather than parity (total number of livebirths).
Endometrial cancer incidence rates were calculated by dividing the number of new cases by the number of person-years of follow-up. Age-adjusted relative risks were calculated by the Mantel-Haenszel procedure using four age categories: 55-59, 60-64, 65-69, and 70 or more years (22) . Test for trend was computed using the Mantel-Haenszel extension test (23) . A 95 percent confidence interval was computed for all relative risks.
Multivariate analyses utilized Cox proportional hazards regression. Initially, separate two-factor models were constructed using age and each independent variable of interest. Next, gravidity was added to each model to test for confounding or effect modification. Finally, other known endometrial cancer risk factors (e.g., BMI and estrogen use) were entered in a stepwise fashion to develop a best model. SAS (24) was used for all analyses.
RESULTS
Over the 5 years of follow-up, 167 women in the cohort at risk developed endometrial cancer. At baseline, cases were, on average, older and heavier and had a larger waist-to-hip ratio than did noncases (table 1) . Cases were less Likely to be married or to have used oral contraceptives than were noncases, but were more likely to report postmenopausal exogenous hormone use. Hypertension and diabetes mellitus were reported more often by cases, consistent with the observation that cases had greater BMI. A reported prior diagnosis of uterine fibroids was more common among cases than among noncases, but no difference in cigarette smoking was apparent.
The age-adjusted relative risks of endometrial cancer according to selected reproductive factors are presented in table 2. The known inverse association between age at menarche and endometrial cancer incidence was evident in this cohort. Women who started menstruating at age 15 years or older had about one-third the risk of endometrial cancer compared with those starting at age 10 years or younger. Conversely, women who reported age at natural menopause to be 55 years or older had a relative risk of disease 1.87 times (95 percent confidence interval (CI) 1.12-3.09) that of women who had undergone menopause before age 45. Women in the highest quintile of years of ovulation had 3.63 times the risk of endome- trial cancer as did women in the lowest span (test for trend, p < 0.0001).
Gravidity, as expected, was inversely associated with endometrial cancer risk. Women who reported ever being pregnant had only half the risk of endometrial cancer as the nulligravid group. A decrease in risk was also seen with increasing numbers of pregnancies. Women who reported six or more pregnancies had about one-third the risk of women with no pregnancies. Mean gravidity was 2.33 for cases and 3.05 for noncases (p < 0.0001).
More noncases than cases reported a fertility problem (15.5 vs. 12.4 percent), but the difference was not significant, and the age-adjusted relative risk for history of infertility was 0.78 (95 percent CI 0.49-1.26). This lack of association persisted when further analyses were performed to examine the type of infertility problem (ovarian, tubal, uterine, male infertility, or idiopathic infertility). Women in this group whose treatment for infertility was unsuccessful (defined as no subsequent pregnancy) did not have a greater risk of disease than women who went on to have one or more pregnancies.
Age at first pregnancy showed no association with endometrial cancer incidence and was not analyzed further. Older age at last pregnancy appeared protective (table 2) until controlled for gravidity. Older age at last pregnancy was positively associated with higher gravidity, which in turn was associated with lower risk of endometrial cancer. Examination of age at last pregnancy within strata of parity showed no association with endometrial cancer risk.
Miscarriages were reported less frequently by cases than by noncases (18 vs. 26 percent) . When all women, including nulligravid women, were included in the analysis, the relative risk associated with any miscarriage (vs. no miscarriage) was 0.75 (95 percent CI 0.57-0.98). However, the relative risk approximated 1.0 after a variable for total number of pregnancies was added to the model. Similar results were seen when nulligravid women were excluded. Because number of miscarriages was positively associated with gravidity, the results of the regression analysis suggest that it is gravidity that accounts for the reduced risk of disease, not the number of miscarriages directly. Compared with the group of women who had experienced one or more pregnancies, women who were never pregnant had a relative risk of endometrial cancer of 2.01 (95 percent CI 1.34-3.00). Among gravid women, those who experienced only miscarriages and no livebirths had a relative risk of 1.28 (95 percent CI 0.31-5.15) compared with women whose pregnancies produced at least one livebirth. In terms of endometrial cancer risk, it appears to be safer to experience preg- nancies ending in miscarriage only in comparison with not experiencing pregnancy at all.
Timing of miscarriages, however, appeared to influence both the direction and the magnitude of the risk. Table 3 shows that women who experienced a miscarriage in a first or middle pregnancy had only half the risk of endometrial cancer as gravid women with no miscarriages (relative risk = 0.48, 95 percent CI 0.28-0.85). However, compared with the same reference group, women whose miscarriage occurred in a last pregnancy had a relative risk of 1.34 (95 percent CI 0.79-2.26). Results of Cox proportional hazards regression indicated that this association was not explained by differences in gravidity, BMI, estrogen use, and age at last pregnancy.
The total number of induced abortions was small in this cohort of older women. However, six cases (3.6 percent) reported having had one or more induced abortions compared with 396 noncases (1.6 percent), a difference significant at p < 0.05. Cox proportional hazards regression was applied by using as a reference group gravid women who had never had an induced abortion. Women who had undergone an induced abortion had an age-adjusted relative risk of 2.50 for endometrial cancer (95 percent CI 1.10-5.68). Addition of a continuous variable for gravidity to the model slightly increased the relative risk to 2.93 (95 percent CI 1.28-6.68). Further adjustment for estrogen use and BMI slightly attenuated the association (relative risk -2.71, 95 percent CI 1. 19-6.20) .
The outcomes of pregnancies subsequent to the induced abortion were then examined. Of the noncases who had had a previous abortion, 48.3 percent went on to have their last pregnancy end in a livebirth compared with only 16.7 percent of the cases. Conversely, only 4.1 percent of the noncases experienced a miscarriage as the outcome of a last pregnancy compared with 50 percent of the cases (p < 0.001). When a categorical variable to denote miscarriage (yes vs. no) in the last pregnancy was entered in a Cox model, the addition of variables for age, gravidity, estrogen use, and BMI resulted in a relative risk of 1.09.
DISCUSSION
Results of the current study suggest that the risk of endometrial cancer was higher among women who were older, heavier, had not been married, and had not experienced a pregnancy. Endometrial cancer risk was positively associated with early age at menarche, older age at menopause, and use of estrogen replacement therapy. Women who experienced an induced abortion were at higher risk for endometrial cancer, as were women whose last pregnancy ended in a miscarriage. After adjustment for gravidity, no differences were found in history of infertility or in ages at first and last pregnancy.
These findings, for the most part, might be explained on the basis of exposure of the endometrium to increased levels of estrogen, and in particular, to estrogen unopposed by progesterone. This mechanism has been strongly implicated in the development of endometrial cancer (16, 25, 26) . This hormone imbalance can occur because of an excess supply of estrogen, from exogenous hormone intake, or from excessive conversion in adipose tissue of androstenedione to estrone (26) (27) (28) (29) . Alternatively, a hormonal imbalance may result not from an excess of estrogen, but from a deficiency in progesterone, as can occur in the SteinLeventhal syndrome or other ovarian diseases. The administration of exogenous estrogens without exogenous progesterone can also result in a relative progesterone deficiency.
Reproductive factors may also influence the risk of endometrial cancer by affecting relative estrogen/progesterone exposures. The menstrual cycle, pregnancy, miscarriage, induced abortion, and menopause are also associated with fluctuating levels of estrogen and progesterone. The uterus, being a sex hormone-dependent organ, responds to hormonal changes in the body brought about by a woman's reproductive experiences.
Infertility, especially that associated with progesterone deficiency or anovulation, has been linked to increased risk of endometrial cancer in several previous studies (1, 10, (13) (14) (15) , but not the current one. There are several possible reasons for this. First, the questionnaire asked only about trying for a pregnancy without success for a period of 1 year; other studies have used a definition of infertility over a period of 2-3 years or more (1, 14, 16) . It is possible that our definition of infertility allowed inclusion of women who were not truly infertile, thus attenuating any possible association. Second, infertility information obtained by self-report may be less reliable than the medically diagnosed infertility that previous studies have used (1, 10, 14, 15) . Third, population differences across studies may be a factor. Our cohort consisted almost exclusively of postmenopausal women, and some investigators have found infertility to be a risk factor for endometrial cancer only in younger, premenopausal women (8, 13) . While infertility was not found to be a significant risk factor in this study, nulligravidity was. A woman who was classified as "ever pregnant" had less than hah 0 the risk of endometrial cancer as a woman classified as "never pregnant." This finding is in agreement with previous reports on endometrial cancer and gravidity (1) (2) (3) 17) . During pregnancy, there is little mitotic activity in the endometrium, thus reducing the chances of abnormal cell differentiation or proliferation. There is also protection from anovulatory menstrual cycles with their corresponding low production of progesterone. In addition, parturition itself may be protective, as the endometrium undergoes a mechanical exfoliation of its surface cells, thus potentially eliminating any cells in stages of abnormal growth. A protective effect of pregnancy has convincing biologic plausibility, and the findings of the current study add more support to this association.
The role of miscarriages and induced abortions in the etiology of endometrial cancer is still unclear. Most endometrial cancer research has failed to find a statistically significant association with incomplete pregnancies (1, 13, 17, 18) , although a few studies suggested a protective association (5, 7, 16) . Our study does little to clarify the controversy: Miscarriage was associated with lower risk until gravidity was taken into account, suggesting that miscarriage itself did not have a significant independent effect.
Timing of miscarriages in a woman's reproductive life had not previously been examined in relation to endometrial cancer. However, a significantly higher risk of breast cancer has been found in some studies among women who experienced a first-trimester miscarriage or induced abortion before a first full-term pregnancy (30) (31) (32) . We found that women whose last pregnancy ended in a miscarriage had 2.80 times the risk of endometrial cancer compared with women whose miscarriage(s) occurred in a first or middle pregnancy. This finding was highly significant (p = 0.004) and was not confounded by differences in age at last pregnancy, gravidity, BMI, or estrogen use. Women with a miscarriage in a last pregnancy were more likely to be heavy smokers than were women with miscarriages in other-than-last pregnancies, but this difference was not statistically significant. However, in any event, smoking is an unlikely explanation since prior studies on smoking and endometrial cancer have suggested an inverse association (33-35). Women with last-pregnancy miscarriages were also more likely to have used estrogen replacement therapy, but again the difference was not statistically significant and was not likely to have explained our findings. A possible explanation for our finding of higher endometrial cancer risk with last-pregnancy miscarriages may be that some abnormal cell differentiation may already be present in the endometrium, contributing to the miscarriage as well as to endometrial cancer. Since these women had their last-pregnancy miscarriage primarily in their thirties and since their endometrial cancer was not diagnosed until after age 55 years, this would imply a lead time of 20 years or more, a seemingly unlikely scenario. Another possible explanation might be that mechanical trauma to the endometrium during the actual process of the miscarriage itself contributes to malignant transformation. However, we found no association of number of dilation and curettages with risk of endometrial cancer (data not shown). Therefore, if these last-pregnancy miscarriages included a curettage, it does not appear that the procedure itself had a long-term harmful effect. Perhaps the most tenable explanation for increased risk of endometrial cancer is that the women who experienced a miscarriage in their last pregnancy had an existing progesterone deficiency. A progesterone deficiency could result both in an inability to maintain the pregnancy and in later difficulty conceiving another child. As mentioned earlier, endometrial exposure to estrogen unopposed by progesterone is a strong risk factor for endometrial cancer. Viewed in this way, a last-pregnancy miscarriage is not harmful in and of itself, but rather serves as a marker for a hormonal imbalance that may later predispose a woman to endometrial cancer.
Our finding of a statistically significant, positive association between induced abortion and endometrial cancer is, to our knowledge, unique in the literature. Previous studies found either no association (1, 4, 13, 16, 19) or an inverse association (5, 7, 18) . However, the number of cases who reported an induced abortion was so small that it precluded the generalizability of this finding. Of particular interest, however, was the finding that cases who experienced an induced abortion were significantly more likely than noncases to have had a last pregnancy end in miscarriage. This could suggest that among cases with a history of induced abortion, the high relative risk of endometrial cancer may not have been due to their abortion status as much as to the outcome of their last pregnancy. More research is needed in this area.
Our null findings regarding ages at first and last pregnancy generally confirm those found by previous investigators (5, 7, 8, 12, 16, 17) . Two recent studies (4, 11) reported an inverse association between age at last pregnancy and endometrial cancer, and biologically this seems plausible. Women who conceive a pregnancy at older ages must be ovulatory late in life; thus they may be protected from the unopposed estrogen load from anovulatory cycles. There may also be a mechanical, protective effect of a late-age pregnancy and delivery. Our cases were, in fact, younger at their last pregnancy than were noncases (30.6 years vs. 31.7 years, p = 0.02), but this finding was explained by differential gravidity.
Taken together, our results lend support to the prevailing view that endometrial exposure to estrogen without the opposing effect of progesterone can increase the risk of endometrial cancer. Our cases were heavier, had an earlier menarche and a later menopause, experienced a longer ovulation span, were more likely to use exogenous estrogens, and had fewer births than did noncases. These findings are all consistent with a hormonally induced endometrial cancer risk hypothesis. Our data on the timing of miscarriage also support such a hypothesis. The increased cancer risk associated with a last-pregnancy miscarriage may indicate a progesterone deficiency that leads both to pregnancy loss and to subsequent inability to conceive another pregnancy. Eventually, such a hormonal imbalance may increase risk of endometrial cancer. The results suggest a need to examine this further.
